Systematic review / meta-analysis / 2020
A systematic review of five clinical trials found sulforaphane use was positively correlated with improved behavior and cognitive function in ASD.
This systematic review assessed sulforaphane therapy as a treatment for individuals with autism spectrum disorder across multiple databases. All five included clinical trials reported a significant positive correlation between sulforaphane use and ASD behavior and cognitive function. The authors noted minimal side effects and concluded sulforaphane appears safe and effective for treating ASD.
- Study type
- Systematic review of clinical trials
- Who was studied
- Individuals with autism spectrum disorder (5 clinical trials)
- What was measured
- Behavior and cognitive function
THE PAPER
Sulforaphane treatment for autism spectrum disorder: A systematic review.
McGuinness G, Kim Y. EXCLI J, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.